Decentralized science (DeSci) is gaining ground in the crypto world. DeSci is built on the idea of decentralization and uses tools, like NFTs, DAO, and smart contracts, to steer science from the control of centralized entities in order to promote peer review that will drive transparency in science. Simply put, they no longer want the big brands to control the narrative. They want to promote science that the everyday person can have access to and be empowered by.
This is why VitaDAO has recently raised $4.1 million to back research that could potentially extend human life. This funding was raised by Pfizer Ventures, Beaker DAO, Shine Capital, L1 Digital, Spaceship DAO, Balaji Srinivasan, and Joe Betts-LaCroix.
The money raised in this funding will enable VitaDAO to launch its first biotech startup which will be unveiled in the first quarter of 2023 as well as fund its longevity research.
The fundraising is a crucial step in VitaDAO’s plan and will allow it to fund cutting-edge longevity research, make new technologies that combat human aging commercially available, and open its doors to collaborate with more experts and extension of healthspan enthusiasts globally.
VitaDAO is a decentralized autonomous organization (DAO) passionate about longevity. It was founded by Tyler Golato in 2021, and it boasts a community of 9000 enthusiasts, contributors, and researchers who promote research and development in the extension of human life and the healthspan industry.
To make this happen, VitaDAO funds and makes research publicly available in the form of IP-NFTs. It also supports new biotech companies. So far, VitaDAO has invested more than $3.5 million in approximately 15 projects. These include $1 million to Turn Bio, a company that develops mRNA drugs that make the body heal by instructing specific cells to repair damaged tissues or fight disease and $350,000 to Rebedo Life to selectively combat pathogenic cells and age-related diseases. DAOs, like VitaDAO, could be the game changer for biotech innovation.